Methacrylic Acid
Excipient (pharmacologically inactive substance)
What is it?
Methacrylic acid is the parent or precursor compound for many ester products used in pharmaceutical manufacturing, such as methacrylic acid coploymer. Many of the final ester compounds are used as excipients in manufacture of enteric coatings and delayed-release products.[1]
[1] Dow Chemicals. Methacrylic acid esters: Background Information. Accessed 8/15/2012. http://www.dow.com/assets/attachments/business/pmat/methacrylate_esters_background_information.pdf
Top Medications with this excipient
- Bupropion Hydrochloride Extended-Release (XL) 150 mg (Actavis)
- Bupropion Hydrochloride Extended-Release (XL) 300 mg (Actavis)
- Didanosine 400 mg (Teva Pharmaceuticals USA)
- Didanosine 200 mg (Teva Pharmaceuticals USA)
- Didanosine 250 mg (Teva Pharmaceuticals USA)
- Divalproex Sodium Delayed-Release 125 mg (Zydus Pharmaceuticals)
- Divalproex Sodium Delayed-Release 250 mg (Zydus Pharmaceuticals)
- Divalproex Sodium Delayed-Release (Sprinkle) 125 mg (Zydus Pharmaceuticals)
- Entocort EC 3 mg (Prometheus Laboratories Inc.)
- Ketoprofen Extended Release 200 mg (Mylan Pharmaceuticals Inc.)
- Lamictal XR 300 mg (GlaxoSmithKline)
- Naproxen Enteric Coated 375 mg (Sandoz Pharmaceuticals Inc.)
- Naproxen Enteric Coated 500 mg (Sandoz Pharmaceuticals Inc.)
- Nexium 20 mg (AstraZeneca Pharmaceuticals)
- Nexium 40 mg (AstraZeneca Pharmaceuticals)
- Omeprazole 20 mg (Mylan Pharmaceuticals Inc.)
- Omeprazole 10 mg (Mylan Pharmaceuticals Inc.)
- Omeprazole Delayed Release 40 mg (Mylan Pharmaceuticals Inc.)
- Tamsulosin Hydrochloride 0.4 mg (Zydus Pharmaceuticals)
- Vimovo esomeprazole 20 mg / naproxen 500 mg (AstraZeneca Pharmaceuticals)
